Teva Pharmaceutical Industries
TEVA
$8.36
Share price
0.00%
Change (1 day)
5.42%
Change (1 year)
Categories
Teva Pharmaceutical Industries (TEVA) - Total assets
Total assets on the balance sheet as of December 2022 : $44.00 B
According to Teva Pharmaceutical Industries's latest financial reports the company's total assets are $44.00 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Teva Pharmaceutical Industries - Total assets on balance sheet (from 2001 to 2022)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2021-12-31 | $47.66 B | -5.87% |
| 2020-12-31 | $50.64 B | -11.88% |
| 2019-12-31 | $57.47 B | -5.29% |
| 2018-12-31 | $60.68 B | -14.07% |
| 2017-12-31 | $70.61 B | -23.98% |
| 2016-12-31 | $92.89 B | 71.2% |
| 2015-12-31 | $54.25 B | 16.88% |
| 2014-12-31 | $46.42 B | -2.29% |
| 2013-12-31 | $47.50 B | -6.13% |
| 2012-12-31 | $50.60 B | 0.93% |
| 2011-12-31 | $50.14 B | 31.43% |
| 2010-12-31 | $38.15 B | 12.84% |
| 2009-12-31 | $33.81 B | 2.75% |
| 2008-12-31 | $32.90 B | 40.54% |
| 2007-12-31 | $23.41 B | 14.37% |
| 2006-12-31 | $20.47 B | 97.08% |
| 2005-12-31 | $10.38 B | 7.84% |
| 2004-12-31 | $9.63 B | 62.82% |
| 2003-12-31 | $5.91 B | 27.86% |
| 2002-12-31 | $4.62 B | 33.72% |
| 2001-12-31 | $3.46 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $117.45 B | 166.90% | 🇨🇭 Switzerland |
 Pfizer PFE | $197.20 B | 348.13% | 🇺🇸 USA |
 Sanofi SNY | $133.42 B | 203.20% | 🇫🇷 France |
 Merck MRK | $109.16 B | 148.06% | 🇺🇸 USA |
 AstraZeneca AZN | $96.48 B | 119.25% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $72.89 B | 65.66% | 🇬🇧 UK |
 Dr. Reddy's RDY | $3.57 B | -91.89% | 🇮🇳 India |